Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corbus Pharmaceuticals Holdings Inc shares valued at $20,465 were sold by Jenkins John Kenneth on May 30 ’25. At $7.35 per share, Jenkins John Kenneth sold 2,783 shares. The insider’s holdings dropped to 33 shares worth approximately $274.23 following the completion of this transaction.
Also, Altmeyer Anne sold 1,392 shares, netting a total of over 10,096 in proceeds. Following the sale of shares at $7.25 each, the insider now holds 1,391 shares.
Before that, Smethurst Dominic had sold 6,393 shares from its account. In a trade valued at $43,330, the Chief Medical Officer traded Corbus Pharmaceuticals Holdings Inc shares for $6.78 each. Upon closing the transaction, the insider’s holdings decreased to 6,393 shares, worth approximately $0.59 million.
As published in their initiating research note from William Blair on February 28, 2025, Corbus Pharmaceuticals Holdings Inc [CRBP] has been an Outperform. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of July 30, 2024, Wedbush has initiated its “an Outperform” rating for CRBP.
Analyzing CRBP Stock Performance
On last trading session,, Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] rose 0.36% to $8.31. During the last five days, there has been a drop of approximately -7.36%. Over the course of the year, Corbus Pharmaceuticals Holdings Inc shares have dropped approximately -29.58%. Shares of the company reached a 52-week high of $13.28 on 01/16/25 and a 52-week low of $4.64 on 04/07/25.
Support And Resistance Levels for Corbus Pharmaceuticals Holdings Inc (CRBP)
According to the 24-hour chart, there is a support level at 8.12, which, if violated, would cause prices to drop to 7.92. In the upper region, resistance lies at 8.49. The next price resistance is at 8.66. RSI (Relative Strength Index) is 52.95 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Corbus Pharmaceuticals Holdings Inc (CRBP)?
In terms of Corbus Pharmaceuticals Holdings Inc share price expectations, FactSet research, analysts set an average price target of 60 in the next 12 months, up nearly 624.64% from the previous closing price of $8.28. Analysts anticipate Corbus Pharmaceuticals Holdings Inc stock to reach 82 by 2025, with the lowest price target being 35. In spite of this, 4 analysts ranked Corbus Pharmaceuticals Holdings Inc stock as Buy at the end of 2025. On June 26, 2024, B. Riley Securities assigned a price target of “a Buy” to the stock and initiated coverage with a $85.
